Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for LifeMD (LFMDP) over the last 10 years, with Q3 2025 value amounting to $269000.0.

  • LifeMD's Amortizatization of Intangibles rose 934.96% to $269000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year increase of 2552.76%. This contributed to the annual value of $8.0 million for FY2024, which is 4786.03% up from last year.
  • Latest data reveals that LifeMD reported Amortizatization of Intangibles of $269000.0 as of Q3 2025, which was up 934.96% from $261000.0 recorded in Q2 2025.
  • LifeMD's Amortizatization of Intangibles' 5-year high stood at $2.3 million during Q1 2025, with a 5-year trough of $617.0 in Q3 2021.
  • Over the past 5 years, LifeMD's median Amortizatization of Intangibles value was $297500.0 (recorded in 2022), while the average stood at $711573.5.
  • In the last 5 years, LifeMD's Amortizatization of Intangibles plummeted by 9926.46% in 2021 and then skyrocketed by 5273630.47% in 2022.
  • LifeMD's Amortizatization of Intangibles (Quarter) stood at $617.0 in 2021, then soared by 151424.8% to $934908.0 in 2022, then surged by 75.11% to $1.6 million in 2023, then soared by 30.49% to $2.1 million in 2024, then plummeted by 87.41% to $269000.0 in 2025.
  • Its last three reported values are $269000.0 in Q3 2025, $261000.0 for Q2 2025, and $2.3 million during Q1 2025.